Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-01-12 @ 10:05 PM
Study NCT ID:
NCT00083005
Status:
COMPLETED
Last Update Posted:
2012-03-15
First Post:
2004-05-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate
Sponsor:
National Institutes of Health Clinical Center (CC)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03
Start Date Type:
None
Primary Completion Date:
2007-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-12
Completion Date Type:
ACTUAL
First Submit Date:
2004-05-14
First Submit QC Date:
None
Study First Post Date:
2004-05-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-03-14
Last Update Post Date:
2012-03-15
Last Update Post Date Type:
ESTIMATED